Category Archives: Myocardial Infarction

DANVERS, Mass.--(BUSINESS WIRE)-- Abiomed (ABMD) will highlight the benefits of complete revascularization with Protected PCI and the value of Impella protocol-based treatment for survival and native heart recovery in cardiogenic shock patients at the 31st Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco from September 25-29. During the conference, Abiomed will also offer hands-on training to help physicians improve access and closure skills and patient management expertise to achieve improved outcomes. This press release features multimedia. Continue reading →

A profound analysis of the industry based on the "Myocardial Infarction Drug Market" all over the world is named as Global Myocardial Infarction Drug Market Report. The research report assesses the current as well as the upcoming performance of the Myocardial Infarction Drug market, in addition to with newest trends in the market Continue reading →

Ischemic heart disease is one of the leading causes of morbidity and death worldwide. Continue reading →

September 18, 2019 Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-sensitivity cardiac troponin T (hs-cTnT) protocol is safe, according to recent research. The late-breaking results from the RAPID-TnT trial were presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2019, Aug. Continue reading →

Young adults with diabetes who experience an acute myocardial infarction (MI) tend to see significant health status improvements in the subsequent year and are not significantly worse off than patients who did not have diabetes at the time of acute MI, according to study results published in the Journal of the American Heart Association. To evaluate the relationship between diabetes and health status in the 12 months after acute MI, researchers used data from 3501 adults (aged 18-55 years) with documented acute MI enrolled in the VIRGO study (ClinicalTrials.gov Identifier: NCT00597922). They assessed each patient using the Seattle Angina Questionnaire for disease-specific health status, the 12-item Short-Form Health Survey (SF-12) for general physical and mental functioning, and the EuroQol-5 Dimensions Visual Analogue Scale for general quality of life Continue reading →

OBJECTIVE: ST-segment elevation acutemyocardial infarction(STEMI) in very young adults is uncommon. Many studies have focused on the cutoff of 45-50 years old to define young patients with STEMI leaving limited data on the group of very young patients aged less than 35 years old. We investigated the incidence of STEMI in different subgroups of young patients and focused on the characteristics, possible pathogenesis and outcomes in very young patients aged less than 35 years old. Continue reading →

IRVINE, Calif.--(BUSINESS WIRE)-- TherOx, a ZOLL Medical company, announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO2) Therapy at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium Sept. 25-29 at the Moscone Center in San Francisco. Presentations include an overview and case study of SSO2 Therapy the first and only FDA-approved new heart attack treatment beyond PCI to reduce infarct size and updated results of the IC-HOT (Evaluation of Intracoronary Hyperoxemic Oxygen Therapy) study conducted to support FDA approval, granted in April 2019 Continue reading →

Self Regional Healthcare, a participant in the American Heart Association Mission: Lifeline Regional Reports, has received the Mission: Lifeline Regional STEMI Trailblazer Achievement Award as a part of the South Carolina Region. The award is presented for implementing specific quality improvement measures at a regional level as outlined by the Association for treating patients who suffer severe heart attacks. This is the first year the Association has recognized regional achievement as part of its awards program for quality patient care Every year, more than 250,000 people experience an ST elevation myocardial infarction (STEMI), the deadliest type of heart attack, caused by a blockage of blood flow to the heart that requires timely treatment. Continue reading →

WASHINGTON: As the cannabis industry continues to evolve, researchers are constantly uncovering positive aspects of the plant. A study by the University of Colorado suggests that cannabis can be used to increase the survivability of a heart attack Continue reading →

Myocardial infarction or heart attack is an irreversible acute medical condition, which leads to the necrosis of heart muscles secondary to extended ischemia. Myocardial infarction occurs when a part of heart is deprived of oxygen, which is caused due to the blockage of one of the coronary arteries. Usually blockage is developed due to the buildup of atherosclerotic plaque on the walls of arteries. Continue reading →